Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia

Y Persidsky1, J Zheng, D Miller

  • 1Center for Neurovirology and Neurodegenerative Disorders, the Department of Pathology, University of Nebraska Medical Center, Omaha 68198-5215, USA. ypersids@unmc.edu

Journal of Leukocyte Biology
|September 14, 2000
PubMed

Insights

HIV-1 infection causes brain immune cells to release chemokines, which contribute to HIV-1 encephalitis and dementia by affecting brain cells and neuron function.

Area of Science:

  • Neuroscience
  • Immunology
  • Virology

Background:

  • HIV-1 neuropathogenesis involves immune-activated brain mononuclear phagocytes (MP) producing secretory factors.
  • MP-secreted chemokines are implicated in HIV-1 encephalitis (HIVE), potentially promoting macrophage infiltration and blood-brain barrier (BBB) dysfunction.

Purpose of the Study:

  • To investigate how HIV-1-infected MP regulate chemokine production.
  • To understand the influence of these chemokines on HIV-1 neuropathogenesis and HIV-1-associated dementia.

Main Methods:

  • Laboratory assays and analysis of infected brain tissue to assess chemokine production by HIV-1-infected MP (microglia, astrocytes).
  • Utilizing a BBB model system and SCID mice with HIVE to evaluate the impact of HIV-1-infected microglia on monocyte migration.
  • Examining human autopsy brain tissue and SCID mice with HIVE to assess effects on brain microvascular endothelial cells and tight junction proteins.

Main Results:

  • HIV-1-infected and immune-activated MP, including microglia and astrocytes, were found to produce abundant beta-chemokines.
  • HIV-1-infected microglia significantly altered monocyte migration in both BBB models and HIVE models in SCID mice.
  • HIV-1-infected MP were shown to down-regulate tight junction proteins and polarized transport systems in brain microvascular endothelial cells.

Conclusions:

  • Chemokines play diverse and significant roles in HIV-1 neuropathogenesis, contributing to BBB dysfunction and neuronal damage.
  • The binding of chemokines like stromal-derived factor-1alpha to neuronal receptors can directly cause neurotoxicity.
  • These findings provide a foundation for developing future therapeutic strategies targeting chemokine pathways in HIV-1-associated neurological disorders.

Related Concept Videos

The Blood-brain Barrier00:49

The Blood-brain Barrier

Overview
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...